Published in Cardiovascular Week, September 3rd, 2007
If the technique, which was tested on animal models in the study, proves viable in humans, it could pave the way for therapies that could prevent the condition from progressing and bringing on coronary heart disease and stroke, two of the nationís most lethal diseases. Such therapies could be applied at the onset of inflammation years before present screening methods would detect...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.